Diogo Dalot Joins Cristiano Ronaldo in Bioniq by Investing Over €1 Million

Dalot, who plays for Manchester United and the Portugal national team, joins Cristiano Ronaldo, who became a major investor in 2024. This brings it’s total value to €74.8 million.

Vadim Fedotov, Founder and CEO of Bioniq said, “Diogo has an exceptional approach to performance optimisation and recovery, constantly seeking the most effective and scientifically backed methods to enhance his physical and cognitive capabilities, His dedication to craft and commitment to maximising potential makes him a perfect fit for Bioniq. He shares our vision and mission, recognising that the future of health lies in precision, personalisation, and efficacy. His investment is yet another testament to this shift — where science-driven, individualised solutions create meaningful impact in the industry and everyday well-being.”

Dalot has been using Bioniq’s products for over four years to improve his health and performance. He also works closely with the Bioniq team to help develop new products, sharing his experience as a professional athlete.

Read also - EcoDataCenter funding news – EcoDataCenter Secures €450 Million in Funding

With the launch of Bioniq’s new "Build Your Own" supplement, Dalot has created a more customized routine, adjusting his nutrient intake based on his goals. While the PRO formula helps reduce inflammation and boost endurance, the "Build Your Own" formula allows for mild inflammation, which is a natural part of building muscle.

Diogo Dalot said, “When it comes to high-level performance, my biggest focus has always been finding that extra 1% — the key to setting myself apart from the rest. Since discovering Bioniq in 2022, it’s been a game-changer for me. I’ve seen the results for myself. Achieving such progress is only possible with a product that’s truly personalised and tailored specifically to my needs Now I’m thrilled to take the next step as an investor. I believe in Bioniq’s mission and see the tremendous potential of this business, especially with the growing global demand for personalised nutrition.”

It was created to improve the physical and mental performance of Olympic athletes. Now, its products are available in 70 countries, with the user base growing more than 10 times in 2024. The global supplements market was worth €162 billion in 2023 and is expected to grow by 9.1% each year from 2024 to 2030.

Dalot’s investment follows Cristiano Ronaldo’s 2024 investment and a successful Series B funding round that raised €13.7 million, led by top European investors HV Capital and Unbound.

It uses clear before-and-after data on users’ nutrient needs and progress, which has helped it form partnerships with major health and sports organizations like Lanserhof and UFC. Many athletes, from World Cup champions to NBA stars and Iron Man winners, use Bioniq.

About Bioniq

Bioniq is an innovative health tech company that uses a unique biochemical database and patented technology to create fully personalized solutions for health improvement.